Heart Failure

• FDA label_change · 2012-07-11
  FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for furosemide from Chartwell RX, LLC, resulting in changes to the drug's labeling.

• FDA label_change · 2012-02-17
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)

  The FDA approved a supplemental application for enalapril maleate (Oceanside Pharmaceuticals), resulting in a labeling update for the produc…

• FDA label_change · 2010-02-05
  FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)

  The FDA approved a supplemental application for LANOXIN (digoxin) from Advanz Pharma (US) Corp., resulting in labeling changes for the produ…

• FDA label_change · 2008-08-14
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Amici Pharma, Inc)

  FDA approved a supplemental application for enalapril maleate from Amici Pharma, Inc., resulting in labeling changes for the product.

• FDA label_change · 2008-05-29
  FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)

  FDA Supplemental Application for Lotensin (benazepril hydrochloride) submitted by Validus Pharmaceuticals LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2007-03-14
  FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)

  FDA approved a supplemental application for TOPROL XL (metoprolol succinate) submitted by Melinta Therapeutics, LLC.

• FDA label_change · 2006-12-20
  FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)

  The FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC. The approval indicates an update to…